IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $83,000 | -91.7% | 6,600 | -91.3% | 0.01% | -93.4% |
| Q4 2016 | $1,006,000 | -41.2% | 75,960 | +5.1% | 0.12% | -32.2% |
| Q3 2016 | $1,712,000 | +1823.6% | 72,256 | +2243.7% | 0.18% | +1400.0% |
| Q2 2016 | $89,000 | +178.1% | 3,083 | +208.3% | 0.01% | +200.0% |
| Q1 2016 | $32,000 | -68.9% | 1,000 | -58.3% | 0.00% | -75.0% |
| Q4 2015 | $103,000 | +267.9% | 2,400 | +200.0% | 0.02% | +300.0% |
| Q3 2015 | $28,000 | -53.3% | 800 | -38.5% | 0.00% | -50.0% |
| Q2 2015 | $60,000 | +42.9% | 1,300 | -7.1% | 0.01% | +33.3% |
| Q2 2014 | $42,000 | -54.8% | 1,400 | -62.0% | 0.01% | -60.0% |
| Q4 2013 | $93,000 | -69.9% | 3,684 | -81.6% | 0.02% | -74.1% |
| Q1 2013 | $309,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |